These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1160 related articles for article (PubMed ID: 31912804)
1. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway. Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804 [TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway. Liu J; Zhang S; Fan X; Yuan F; Dai J; Hu J Spine (Phila Pa 1976); 2019 Jan; 44(2):E74-E81. PubMed ID: 29975331 [TBL] [Abstract][Full Text] [Related]
3. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031 [TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Attenuates Myocardial Injury Induced by Renal Ischemia/Reperfusion by Inhibiting the HMGB1-TLR4-MyD88-NF-κB Signaling Pathway. Zhang B; Zhang J; Ainiwaer Y; He B; Geng Q; Lin L; Li X Ann Clin Lab Sci; 2021 May; 51(3):376-384. PubMed ID: 34162568 [TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway. Xue BB; Chen BH; Tang YN; Weng CW; Lin LN Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750 [TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway. Yang YF; Peng K; Liu H; Meng XW; Zhang JJ; Ji FH Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):353-361. PubMed ID: 27998004 [TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway. Zhang JJ; Peng K; Zhang J; Meng XW; Ji FH PLoS One; 2017; 12(2):e0172006. PubMed ID: 28222157 [TBL] [Abstract][Full Text] [Related]
8. Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway. Xing Y; Zhong L; Guo J; Bao C; Luo Y; Min L J Integr Neurosci; 2024 Aug; 23(8):142. PubMed ID: 39207074 [TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling. Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282 [TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine preconditioning plays a neuroprotective role and suppresses TLR4/NF-κB pathways model of cerebral ischemia reperfusion. Wang SL; Duan L; Xia B; Liu Z; Wang Y; Wang GM Biomed Pharmacother; 2017 Sep; 93():1337-1342. PubMed ID: 28753906 [TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine Alleviates CCI-Induced Neuropathic Pain via Inhibiting HMGB1-Mediated Astrocyte Activation and the TLR4/NF-κB Signaling Pathway in Rats. Zhao E; Bai L; Li S; Li L; Dou Z; Huang Y; Li Y; Lv Y Neurotox Res; 2020 Oct; 38(3):723-732. PubMed ID: 32607919 [TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway. Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929 [TBL] [Abstract][Full Text] [Related]
13. [Acacetin protects rats from cerebral ischemia-reperfusion injury by regulating TLR4/NLRP3 signaling pathway]. Lin LM; Song ZY; Hu J Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6107-6114. PubMed ID: 38114218 [TBL] [Abstract][Full Text] [Related]
14. Salvianolic Acid D Alleviates Cerebral Ischemia-Reperfusion Injury by Suppressing the Cytoplasmic Translocation and Release of HMGB1-Triggered NF- Zhang W; Song J; Li W; Kong D; Liang Y; Zhao X; Du G Mediators Inflamm; 2020; 2020():9049614. PubMed ID: 32410871 [TBL] [Abstract][Full Text] [Related]
16. Qingda granule alleviates cerebral ischemia/reperfusion injury by inhibiting TLR4/NF-κB/NLRP3 signaling in microglia. Cai Q; Zhao C; Xu Y; Lin H; Jia B; Huang B; Lin S; Chen D; Jia P; Wang M; Lin W; Zhang L; Chu J; Peng J J Ethnopharmacol; 2024 Apr; 324():117712. PubMed ID: 38184025 [TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway. Chen H; Sun X; Yang X; Hou Y; Yu X; Wang Y; Wu J; Liu D; Wang H; Yu J; Yi W Bosn J Basic Med Sci; 2018 May; 18(2):162-169. PubMed ID: 29510084 [TBL] [Abstract][Full Text] [Related]
18. The protective effect of uric acid in reducing TLR4/NF-κB activation through the inhibition of HMGB1 acetylation in a model of ischemia-reperfusion injury in vitro. Cheng GM; Wang RL; Zhang B; Deng XY Mol Biol Rep; 2020 Apr; 47(4):3233-3240. PubMed ID: 32095984 [TBL] [Abstract][Full Text] [Related]